Clinical Research (Phase IIb-IIIa)
Overview |
 |
Your clinical research is increasingly burdened by high costs, ever-changing regulatory requirements, disparate databases and a limited supply of investigators and patients. These barriers can slow your drug development process and stall commercial success.
Covance delivers the competencies, resources and systems you need to cover every aspect of the drug development process. In 2003 alone, our Phase II-IV comprehensive services were delivered globally across multiple therapeutic specialties, at nearly 25,000 active study sites.
Our innovative scientists, clinicians, regulators and health economics experts are committed to the highest quality standards. We challenge assumptions about traditional clinical trial design and management so that you receive useable, clean data within budget, on time, every time.
Around the world, Covance offices share global SOPs, communications systems and the high standards of quality that ensure excellence in all our efforts.
In addition to therapeutic experience across multiple therapeutic specialties, Covance maintains centers of excellence in study design and clinical development in oncology, CNS, infectious diseases and cardiovascular. |
|
 |
|
|
|
|
|
